276 related articles for article (PubMed ID: 6945426)
1. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
Tsujimoto M
J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
[No Abstract] [Full Text] [Related]
2. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
Kishimoto T
Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
[No Abstract] [Full Text] [Related]
3. [Potentiation of immune responses to influenza split virus vaccine by synthetic 6-O-acyl-muramylpeptides].
Okunaga T
Osaka Daigaku Shigaku Zasshi; 1980 Jun; 25(1):29-52. PubMed ID: 6935421
[No Abstract] [Full Text] [Related]
4. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
Dzheksenbaev OSh
Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
[No Abstract] [Full Text] [Related]
5. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
[No Abstract] [Full Text] [Related]
6. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
7. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
8. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
Audibert F; Chedid L
Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
[No Abstract] [Full Text] [Related]
9. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y
Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688
[No Abstract] [Full Text] [Related]
11. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
Tsujimoto M; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
[TBL] [Abstract][Full Text] [Related]
12. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
[TBL] [Abstract][Full Text] [Related]
14. [Increase of non-specific resistance to infection by synthetic adjuvants].
Parant M; Chedid L
C R Seances Soc Biol Fil; 1979; 173(2):201-12. PubMed ID: 159749
[TBL] [Abstract][Full Text] [Related]
15. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses.
Pearse MJ; Drane D
Vaccine; 2004 Jun; 22(19):2391-5. PubMed ID: 15193400
[TBL] [Abstract][Full Text] [Related]
16. Role of monoaminergic neurotransmitter systems in MDP-induced adjuvant effect.
Strnadová V; Masek K
Methods Find Exp Clin Pharmacol; 1991; 13(6):391-5. PubMed ID: 1679149
[TBL] [Abstract][Full Text] [Related]
17. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Adam A; Souvannavong V; Lederer E
Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
[No Abstract] [Full Text] [Related]
18. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
19. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y
Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
